Context Therapeutics Inc.
CNTX
$0.8595
-$0.0134-1.54%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -34.21M | -27.63M | -26.73M | -30.15M | -18.57M |
| Total Depreciation and Amortization | 13.90K | 12.40K | 10.90K | 10.60K | 10.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 15.97M | 15.71M | 15.63M | 15.63M | 915.60K |
| Change in Net Operating Assets | 517.80K | -3.32M | -3.48M | -2.37M | -764.00K |
| Cash from Operations | -17.70M | -15.22M | -14.56M | -16.88M | -18.40M |
| Capital Expenditure | -41.20K | -41.20K | -7.30K | -7.30K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -14.75M | -14.75M | -14.75M | -14.75M | -- |
| Cash from Investing | -14.79M | -14.79M | -14.76M | -14.76M | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 14.54M | 109.34M | 109.34M | 94.80M | 94.80M |
| Repurchase of Common Stock | -44.60K | -44.60K | -44.60K | -44.60K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -15.30K | -15.30K | -- | -- | -- |
| Cash from Financing | 14.48M | 109.28M | 109.29M | 94.76M | 94.80M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18.02M | 79.26M | 79.98M | 63.12M | 76.40M |